References
- 1. Koshland DE. Immortality and risk assessment (editorial). Science 1987;236–41.
- 2. Brennan TA. The acquired immunodeficiency syndrome (AIDS) as an occupational disease (editorial). Ann Int Med 1987;107:581–3.
- 3. Harrington JM, Shannon HS. Mortality study of pathologists and medical laboratory technicians. Br Med J 1975;2:329–32.
- 4. Harrington JM, Shannon HS. Incidence of tuberculosis, hepatitis, brucellosis, and shigellosis in British medical laboratory workers. Br Med J 1976;1:759–62.
- 5. Harrington JM, Shannon HS. Survey of safety and healthcare in British medical laboratories. Br Med J 1977;1:626–8.
- 6. Acute hepatitis B in laboratory staff: reports to the CDC during seven epidemiological years, mid 1970–1979. Commun Dis Rep 1979;79:48.
- 7. Centers for Disease Control, U. S. Public Health Service, Department of Health and Human Resources. Recommendations for prevention of HIV in healthcare settings. MMWR I978;3ó (suppl No. 2S).
- 8. Pattison CP, Maynard JE, Berquist DR, Webster HM. Epidemiology of hepatitis B in hospital personnel. Am J Epidemiol 1975;101:59–64.
- 9. Weiss SH, Goedert JJ, Gartner S et al. Risk of human immunodeficiency (HIV-1) infection among laboratory workers. Science 1988;239:68–71.
- 10. Levy BS, Harris JC, Smith JL et al. Hepatitis B in ward and clinical laboratory employees of a general hospital. Am J Epidemiol 1977;106:330–5.
- 11. West DJ. The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci 1984;287:26–33.
- 12. Lennox JL, Redfield RR, Burke DS. HIV antibody screening in a general hospital population (letter). JAMA 1987;257:2914.
- 13. McCray E. The Cooperative Needlestick Surveillance Group. Occupational risk of the acquired immunodeficiency syndrome among healthcare workers. N Engl J Med 1986;314:1127–32.
- 14. Lifson AR, Castro KG, McCray E, Jaffe HW. National surveillance of AIDS in healthcare workers. JAMA 1986;256:3231–4.
- 15. Henderson DK, Saah AJ, Zak BJ et al. Risk of nosocomial infection with human T-cell lymphotropic virus type I⊓/lymphadenopathy-associated virus in a large cohort of intensively exposed healthcare workers. Ann Int Med 1986;104:644–7.
- 16. Gottfried EL. Acquired immunodeficiency syndrome and the clinical laboratory worker (editorial). Arch Pathol Lab Med 1987;111:1024–5.
- 17. McEvoy M, Porter K, Mortimer P, Simmons N, Shanson D. Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or body fluids from patients infected with HIV. Br Med J 1987;294:1595–7.
- 18. Gerberding JC, Hopewell PC, Kanninskyls LS, Sande M. Transmission of hepatitis B without transmission of AIDS by accidental needlestick. N. Engl J Med 1985;312:56–7.
- 19. Centers for Disease Control, U. S. Public Health Service, Department of Health and Human Resources. Update: human immunodeficiency virus infections in health care workers exposed to blood of infected patients. MMWR 1987;36:285–9.
- 20. Ringertz MB, Zettenberg B. Serum hepatitis among Swedish track finders. N Engl J Med 1967;276:540–6.
- 21. Zuckerman AJ. The occupational hazards of viral hepatitis. Proc R Soc Med 1971;64:1211–2.
- 22. Centers for Disease Control, U. S. Public Health Service, Department of Health and Human Resources. Acquired immunodeficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR 1982;31;577–80.
- 23. Office of Occupational Medicine. The risk of hepatitis B infection for workers in the healthcare delivery system and suggested methods for risk reduction. Appendix A, OSHA Instruction CPL 2–2.36. Washington: Occupational Safety and Health Administration, Department of Labor, 1983.
- 24. Percy-Robb IW, Proffitt J, Whitby LG. Precautions adopted in a clinical chemistry laboratory as a result of an outbreak of serum hepatitis affecting hospital staff. J Clin Pathol 1970;23:751–6.
- 25. Department of Labor/Department of Health and Human Services. Joint Advisory Notice; HBVZHIV. Fed Reg 1987;52(210): 41818–24.
- 26. Follett EA, Sleigh JD. Hepatitis B as a hazard to laboratory staff: a reappraisal. J Clin Pathol 1980;33:1017–20.
- 27. Handsfield HH, Cummings MJ, Swenson PD. Prevalence of antibody to human immunodeficiency virus and hepatitis B surface antigen in blood samples submitted to a hospital laboratory. Implications for handling specimens. JAMA 1987;258:3396–7.
- 28. Hessol NA, Rutherford GW, O’Mallet PM et al. The natural history of human immunodeficiency virus infection in a cohort of homosexual and bisexual men: a 7-year prospective study. Proc III Int Conf AIDS, Washington, 1987.
- 29. Baker JL, Kelen GD, Sivertsonk T, Quinn TC. Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA 1987;257:2609–11.
- 30. Hepatitis in clinical laboratories (editorial). Br Med J 1976;2: 778–9.
- 31. Decker MD, Schaffner W. Risk of AIDS to healthcare workers. JAMA 1986;256:3264–5.
- 32. Gibbs FL, Kasprisin CA eds. Environmental safety in the blood bank. Arlington, VA: American Association of Blood Banks, 1987.
- 33. Bancroft WH, Snitban R, Scott RM et al. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Inf Dis 1977;135:79–85.
- 34. National Committee for Clinical Laboratory Standards. Protection of laboratory workers from infectious disease transmitted by blood and tissue: proposed guideline NCCLS document M29-P. Villanova, PA: NCCLS;I987.
- 35. Richardson JH, Barkley WE eds. Biosafety in microbiological and biomedical laboratories. Washington: Department of Health and Human Services, 1984 (HHS Publication No. [CDC] 86–8395).
- 36. Laver JL, Van Drunner NA, Washburn JW, Balfour HH. Transmission of hepatitis B virus in clinical laboratory areas. J Infect Dis 1979;140:513–16.
- 37. Centers for Disease Control, U. S. Public Health Service, Department of Health and Human Resources. Update: evaluation of HTLV-III associated infection in healthcare personnel—United States. MMWR 1985;34:575–8.
- 38. Songer JR. Decontamination: a probabilistic pursuit. Lab Med 1987;18:758–64.
- 39. Pike RM. Laboratory associated infections: summary and analysis of 3921 cases. Health Labs Sci 1976;13:105–14.
- 40. Pattison CP, Boyer DM, Maynard JE, Kelly PC. Epidemic hepatitis in a clinical laboratory. Possible association with computer card handling. JAMA 1974;230:854–7.
- 41. American Blood Resources Association. ABRA HIV infection control policy. November 1987. Plasmapheresis 1987;1:105–10.
- 42. Gerberding JL. The University of California, San Francisco Task Force on AIDS. Recommended infection control policies for patients with human immunodeficiency virus infection: an update. N Engl J Med 1986;315:1562–4.
- 43. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation of the human T-lymphotropic virus type I⊓/lymphadenopathy-associated virus. J Inf Dis 1985;152:400–3.
- 44. Wetli CV. A previously unrecognized laboratory hazard: hepatitis B antigen-positive control and diagnostic sera. Am J Clin Pathol 1973;59:684–7.
- 45. Occupational Safety and Health Administration. Occupational exposure to hepatitis B virus and human immunodeficiency virus (proposed rule). Fed Reg 1987;52(228): 45438–41.
- 46. Occupational Safety and Health Act of 1970. General Duty Clause, Section 5(a). 29 USC 655.
- 47. CCBC Newsletter. July 17/24, 1987.
- 48. Adinolfi A, Morrison PL, Polly MJ, Rose JM. Anti-A blood group antibodies. J Exp Med 1966;123:951–5.
- 49. Howie JW. The Howie Code for preventing infection in clinical laboratories: comments on some general criticism and specific complaints. Br Med J 1980;280:1071–4.
- 50. Cohen DR. The Howie Code: is the price of safety too high? J Clin Pathol 1982;35:1018–23.
- 51. Crosby PB. Quality is free: the art of making quality free. New York: McGraw Hill;1979.
- 52. Dick EL. Crisis in the lab. Dimens Health Serv 1975;52:30–1.